Brief: China NT Pharma Posts HY Loss Attributable RMB28.2 Million
31/08/2022 14:05
Aug 31 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* HY LOSS ATTRIBUTABLE RMB28.2 MILLION VERSUS LOSS RMB2.7
MILLION
* HY REVENUE RMB120.5 MILLION VERSUS RMB111.2 MILLION
Source text for Eikon: ID:nHKS1zX2Hw
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY